β-adrenergic receptors in the failing heart: The good, the bad, and the unknown

Journal of Clinical Investigation

Volumn 107, Issue 8, 2001, Pages 947-948

  Liggett, S B ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOBUTAMINE; MYOSIN HEAVY CHAIN; PHOSPHOLAMBAN; PROTEIN G; TROPONIN I;

HEART FAILURE; HEART OUTPUT; HYPERTROPHIC CARDIOMYOPATHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; REVIEW;

EID: 0035046061     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI12774     Document Type: Review

References (27)

1. Phospholamban and cardiac contractile function
2. Mechanistic and clinical rationales for using beta-blockers in heart failure
3. 2-adrenergic receptor in nocturnal and non-nocturnal asthma: Evidence that Gly16 correlates with the nocturnal phenotype
4. 2-adrenergic receptor overexpression in mouse hearts
5. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice
6. Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice
7. 2-adrenergic receptor
8. 2-adrenergic receptor to different G proteins by protein kinase A
9. +-exchange
10. Differential targeting of beta-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway
11. Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: Enhanced basal catalytic activity and function without increased cardiomyocyte β-adrenergic signalling
12. Adenylylcyclase increases responsiveness to catecholamine stimulation in transgenic mice
13. Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
14. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy
15. Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene
16. 2-adrenergic receptor
17. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor
18. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation
19. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
20. Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
21. Transgenic Gαq overexpression induces cardiac contractile failure in mice
22. αq-mediated cardiac hypertrophy and ventricular dysfunction
23. αq-overexpressing mice
24. αq overexpressing mouse
25. Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy
26. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy
27. Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation